Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
# Mount
New York, NY 10029Phone+1 212-241-0034Fax+1 212-289-7738
Education & Training
- University of Virginia Medical CenterFellowship, Gastroenterology, 2002 - 2005
- Boston University Medical CenterResidency, Internal Medicine, 1999 - 2002
- University of Maryland School of MedicineClass of 1999
Certifications & Licensure
- NY State Medical License 2005 - 2026
- NJ State Medical License 2022 - 2025
- VA State Medical License 2002 - 2006
Clinical Trials
Publications & Presentations
PubMed
- 101 citationsMolecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.Roser Pinyol, Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué-Gili
Journal of Hepatology. 2021-10-01 - 464 citationsBrivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-...Josep M. Llovet, Thomas Decaens, Jean-Luc Raoul, Eveline Boucher, Masatoshi Kudo
Journal of Clinical Oncology. 2013-10-01 - 240 citationsOutcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.Richard S. Finn, Philippe Merle, Alessandro Granito, Yi Hsiang Huang, György Bodoky
Journal of Hepatology. 2018-08-01
Press Mentions
- Successful Phase 3 Trial of Drug for Liver CancerJanuary 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: